ihc staining Search Results


luxol fast blue/crystal violet lfb  (IHC World)
90
IHC World luxol fast blue/crystal violet lfb
Luxol Fast Blue/Crystal Violet Lfb, supplied by IHC World, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luxol fast blue/crystal violet lfb/product/IHC World
Average 90 stars, based on 1 article reviews
luxol fast blue/crystal violet lfb - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ihc detection kit  (Beijing Solarbio Science)
90
Beijing Solarbio Science ihc detection kit
Ihc Detection Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ihc detection kit/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
ihc detection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pd-1 ihc staining tonsil (ffpe  (Cell Marque)
90
Cell Marque pd-1 ihc staining tonsil (ffpe
Pd 1 Ihc Staining Tonsil (Ffpe, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pd-1 ihc staining tonsil (ffpe/product/Cell Marque
Average 90 stars, based on 1 article reviews
pd-1 ihc staining tonsil (ffpe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
immunohistochemistry (ihc) of notch1  (Human Protein Atlas)
90
Human Protein Atlas immunohistochemistry (ihc) of notch1
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Immunohistochemistry (Ihc) Of Notch1, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemistry (ihc) of notch1/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
immunohistochemistry (ihc) of notch1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ihc staining  (Human Protein Atlas)
90
Human Protein Atlas ihc staining
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Ihc Staining, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ihc staining/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
ihc staining - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
immunohistochemistry (ihc) staining  (Human Protein Atlas)
90
Human Protein Atlas immunohistochemistry (ihc) staining
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Immunohistochemistry (Ihc) Staining, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemistry (ihc) staining/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
immunohistochemistry (ihc) staining - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
von kossa staining kit  (IHC World)
90
IHC World von kossa staining kit
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Von Kossa Staining Kit, supplied by IHC World, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/von kossa staining kit/product/IHC World
Average 90 stars, based on 1 article reviews
von kossa staining kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ihc staining  (Ascari Inc)
90
Ascari Inc ihc staining
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Ihc Staining, supplied by Ascari Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ihc staining/product/Ascari Inc
Average 90 stars, based on 1 article reviews
ihc staining - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
novaultra masson’s trichrome stain kit  (IHC World)
90
IHC World novaultra masson’s trichrome stain kit
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Novaultra Masson’s Trichrome Stain Kit, supplied by IHC World, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/novaultra masson’s trichrome stain kit/product/IHC World
Average 90 stars, based on 1 article reviews
novaultra masson’s trichrome stain kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
fontana-masson staining solution  (IHC World)
90
IHC World fontana-masson staining solution
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Fontana Masson Staining Solution, supplied by IHC World, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fontana-masson staining solution/product/IHC World
Average 90 stars, based on 1 article reviews
fontana-masson staining solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ihc world novaultra masson trichrome stain kit  (IHC World)
90
IHC World ihc world novaultra masson trichrome stain kit
Comparison of the expression of <t>NOTCH1</t> mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.
Ihc World Novaultra Masson Trichrome Stain Kit, supplied by IHC World, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ihc world novaultra masson trichrome stain kit/product/IHC World
Average 90 stars, based on 1 article reviews
ihc world novaultra masson trichrome stain kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
aβ ihc staining  (CH Instruments)
90
CH Instruments aβ ihc staining
Co-localisation of <t>CRP</t> and Aβ <t>immunohistochemical</t> staining (a) Aβ staining (b) CRP staining (c) merge, 100 × magnification .
Aβ Ihc Staining, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aβ ihc staining/product/CH Instruments
Average 90 stars, based on 1 article reviews
aβ ihc staining - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Comparison of the expression of NOTCH1 mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.

Journal: American Journal of Cancer Research

Article Title: Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients

doi:

Figure Lengend Snippet: Comparison of the expression of NOTCH1 mRNA and disease-free survival of breast cancer patients in the Kaplan-Meier Plotter. There are two probes of the NOTCH1 gene: the 218902_at probe is targeted on the 3’-UTR, and the 223508_at probe is targeted on Exon 34 of NOTCH1. A, B. All breast cancer patients. C, D. ER+ breast cancer patients. E, F. HER2+ breast cancer patients. G, H. TNBC patients. 3’-UTR: 3’-untranslated region; ER: estrogen receptor; HER2: human epidermal growth factor receptor Type II; HR: hazard ratio; mRNA: messenger ribonucleic acid; TNBC: triple negative breast cancer.

Article Snippet: The patients with high expression of NOTCH1 had a trend of poor survival after 10 years ( P = 0.22, ). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 3 caption a7 Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas.

Techniques: Comparison, Expressing

Comparison of NOTCH1 mutations in the cBioPortal platform. A. Somatic mutations of NOTCH1 in 13 studies. The x-axis indicates the sequencing number of amino acids, and the y-axis indicates the number of mutations in all studies. B. Details of NOTCH1 gene alterations in 13 studies. C. Comparison of disease-free survival between patients with altered or unaltered NOTCH1 genes. Altered group includes the patients with mutation, fusion, amplification, deep deletion, multiple alteration, and all forms of alteration of NOTCH1 gene. Unaltered group includes patients with wild type NOTCH1 gene in genome-wide sequencing. CNA: copy number alteration.

Journal: American Journal of Cancer Research

Article Title: Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients

doi:

Figure Lengend Snippet: Comparison of NOTCH1 mutations in the cBioPortal platform. A. Somatic mutations of NOTCH1 in 13 studies. The x-axis indicates the sequencing number of amino acids, and the y-axis indicates the number of mutations in all studies. B. Details of NOTCH1 gene alterations in 13 studies. C. Comparison of disease-free survival between patients with altered or unaltered NOTCH1 genes. Altered group includes the patients with mutation, fusion, amplification, deep deletion, multiple alteration, and all forms of alteration of NOTCH1 gene. Unaltered group includes patients with wild type NOTCH1 gene in genome-wide sequencing. CNA: copy number alteration.

Article Snippet: The patients with high expression of NOTCH1 had a trend of poor survival after 10 years ( P = 0.22, ). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 3 caption a7 Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas.

Techniques: Comparison, Sequencing, Mutagenesis, Amplification, Genome Wide

Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas. A. IHC staining of NOTCH1 in tissue microarrays. Left block: stain with CAB008112 antibody. Right block: stain with CAB022466 antibody. B. Results of IHC of NOTCH1. Arrow: more than 75% of cells had positive NOTCH1 staining. Arrowhead: Nuclear staining of NOTCH1. C. Comparison of overall survival between patients with low or high expression of NOTCH1.

Journal: American Journal of Cancer Research

Article Title: Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients

doi:

Figure Lengend Snippet: Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas. A. IHC staining of NOTCH1 in tissue microarrays. Left block: stain with CAB008112 antibody. Right block: stain with CAB022466 antibody. B. Results of IHC of NOTCH1. Arrow: more than 75% of cells had positive NOTCH1 staining. Arrowhead: Nuclear staining of NOTCH1. C. Comparison of overall survival between patients with low or high expression of NOTCH1.

Article Snippet: The patients with high expression of NOTCH1 had a trend of poor survival after 10 years ( P = 0.22, ). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 3 caption a7 Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas.

Techniques: Immunohistochemistry, Blocking Assay, Staining, Comparison, Expressing

Immunohistochemistry (IHC) staining of cNOTCH1 in breast cancer. A. Negative immunoreactivity. B. Weak immunoreactivity. C. Strong immunoreactivity. The main photos are 100× magnification with a 10-μm-scale bar in the left lower corner. The inserted photos in the right lower corner are 400× magnification with a 10-μm-scale bar. The tumors with negative and weak immunoreactivity are grouped as low cNOTCH1 expression, while those with strong immunoreactivity are grouped as high cNOTCH1 expression. D-I. Comparison of different pathological factors and expression of cNOTCH1 by IHC staining. D. Tumor size (P = 0.087). E. Extensive intraductal components (P = 0.009). F. Nipple invasion by cancer (P = 0.043). G. Tumor stage (P = 0.139). H. Nodal stage (P = 0.304). I. AJCC TNM stage (P = 0.063). AJCC TNM stage: American Joint Committee on Cancer tumor, node, metastasis staging system; cNOTCH1: cytosolic NOTCH1 protein.

Journal: American Journal of Cancer Research

Article Title: Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients

doi:

Figure Lengend Snippet: Immunohistochemistry (IHC) staining of cNOTCH1 in breast cancer. A. Negative immunoreactivity. B. Weak immunoreactivity. C. Strong immunoreactivity. The main photos are 100× magnification with a 10-μm-scale bar in the left lower corner. The inserted photos in the right lower corner are 400× magnification with a 10-μm-scale bar. The tumors with negative and weak immunoreactivity are grouped as low cNOTCH1 expression, while those with strong immunoreactivity are grouped as high cNOTCH1 expression. D-I. Comparison of different pathological factors and expression of cNOTCH1 by IHC staining. D. Tumor size (P = 0.087). E. Extensive intraductal components (P = 0.009). F. Nipple invasion by cancer (P = 0.043). G. Tumor stage (P = 0.139). H. Nodal stage (P = 0.304). I. AJCC TNM stage (P = 0.063). AJCC TNM stage: American Joint Committee on Cancer tumor, node, metastasis staging system; cNOTCH1: cytosolic NOTCH1 protein.

Article Snippet: The patients with high expression of NOTCH1 had a trend of poor survival after 10 years ( P = 0.22, ). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 3 caption a7 Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas.

Techniques: Immunohistochemistry, Expressing, Comparison

Comparison of the expression of cNOTCH1 in immunohistochemistry (IHC) and disease-free survival of breast cancer patients. A. All breast cancer patients in the present study. B. ER+ breast cancer patients. C. HER2+ breast cancer patients. D. Triple negative breast cancer (TNBC) patients. E. The patients received standard chemotherapy.HER2: human epidermal growth factor receptor type II; cNOTCH1: cytosolic NOTCH1 protein; TNBC: triple negative breast cancer.

Journal: American Journal of Cancer Research

Article Title: Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients

doi:

Figure Lengend Snippet: Comparison of the expression of cNOTCH1 in immunohistochemistry (IHC) and disease-free survival of breast cancer patients. A. All breast cancer patients in the present study. B. ER+ breast cancer patients. C. HER2+ breast cancer patients. D. Triple negative breast cancer (TNBC) patients. E. The patients received standard chemotherapy.HER2: human epidermal growth factor receptor type II; cNOTCH1: cytosolic NOTCH1 protein; TNBC: triple negative breast cancer.

Article Snippet: The patients with high expression of NOTCH1 had a trend of poor survival after 10 years ( P = 0.22, ). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 3 caption a7 Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas.

Techniques: Comparison, Expressing, Immunohistochemistry

RNA sequencing data from The Cancer Genome Atlas Breast Invasive Carcinoma in Genomic Data Commons Data Portal (GDC TCGA-BRCA) via the Xena platform. Scatter plots of NOTCH1 versus (A) CCNA1 (protein: cyclin A1), (B) CCNA2 (protein: cyclin A2), (C) CCNB1 (protein: cyclin B1), (D) CCND1 (protein: cyclin D1), (E) CCND2 (protein: cyclin D2), (F) CCNE1 (protein: cyclin E1), (G) CDK2 (protein: CDK2), (H) CDK4 (protein: CDK4), (I) CDK6 (protein: CDK6), (J) CDKN1A (protein: p21), (K) CDKN1B (protein: p27), AND (L) CDKN2C (protein: p18). Adjusted P value was calculated by Benjamini-Hochberg procedure.

Journal: American Journal of Cancer Research

Article Title: Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients

doi:

Figure Lengend Snippet: RNA sequencing data from The Cancer Genome Atlas Breast Invasive Carcinoma in Genomic Data Commons Data Portal (GDC TCGA-BRCA) via the Xena platform. Scatter plots of NOTCH1 versus (A) CCNA1 (protein: cyclin A1), (B) CCNA2 (protein: cyclin A2), (C) CCNB1 (protein: cyclin B1), (D) CCND1 (protein: cyclin D1), (E) CCND2 (protein: cyclin D2), (F) CCNE1 (protein: cyclin E1), (G) CDK2 (protein: CDK2), (H) CDK4 (protein: CDK4), (I) CDK6 (protein: CDK6), (J) CDKN1A (protein: p21), (K) CDKN1B (protein: p27), AND (L) CDKN2C (protein: p18). Adjusted P value was calculated by Benjamini-Hochberg procedure.

Article Snippet: The patients with high expression of NOTCH1 had a trend of poor survival after 10 years ( P = 0.22, ). fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 3 caption a7 Immunohistochemistry (IHC) of NOTCH1 in Human Protein Atlas.

Techniques: RNA Sequencing

Co-localisation of CRP and Aβ immunohistochemical staining (a) Aβ staining (b) CRP staining (c) merge, 100 × magnification .

Journal: Journal of Neuroinflammation

Article Title: CRP gene variation affects early development of Alzheimer's disease-related plaques

doi: 10.1186/1742-2094-8-96

Figure Lengend Snippet: Co-localisation of CRP and Aβ immunohistochemical staining (a) Aβ staining (b) CRP staining (c) merge, 100 × magnification .

Article Snippet: CRP IHC staining (positive/negative) was found to be significantly correlated with Aβ (amyloid-β) staining (positive/negative) in all studied brain regions in the cohort, (Chi square p < 0.0001, Figure ).

Techniques: Immunohistochemical staining, Staining

CRP SNPs and prevalence of CRP immunohistochemical staining (positive/negative) with SNPs rs3091244 and rs1130864 . Genotypes in order of population frequency, with * referring to 'no CRP staining' versus 'positive staining' with most common genotype as reference group.

Journal: Journal of Neuroinflammation

Article Title: CRP gene variation affects early development of Alzheimer's disease-related plaques

doi: 10.1186/1742-2094-8-96

Figure Lengend Snippet: CRP SNPs and prevalence of CRP immunohistochemical staining (positive/negative) with SNPs rs3091244 and rs1130864 . Genotypes in order of population frequency, with * referring to 'no CRP staining' versus 'positive staining' with most common genotype as reference group.

Article Snippet: CRP IHC staining (positive/negative) was found to be significantly correlated with Aβ (amyloid-β) staining (positive/negative) in all studied brain regions in the cohort, (Chi square p < 0.0001, Figure ).

Techniques: Immunohistochemical staining, Staining

Results validated by FDR < 0.05 cutoff limit

Journal: Journal of Neuroinflammation

Article Title: CRP gene variation affects early development of Alzheimer's disease-related plaques

doi: 10.1186/1742-2094-8-96

Figure Lengend Snippet: Results validated by FDR < 0.05 cutoff limit

Article Snippet: CRP IHC staining (positive/negative) was found to be significantly correlated with Aβ (amyloid-β) staining (positive/negative) in all studied brain regions in the cohort, (Chi square p < 0.0001, Figure ).

Techniques: Immunohistochemistry